Japan, Jan. 20 -- DICERNA PHARMACEUTICALS INC has got intellectual property rights for 'COMPOSITIONS AND METHODS FOR INHIBITING LPA EXPRESSION.' Other related details are as follows:
Application Number: JP,2024-034617
Category (FI): A61K31/7125,A61P9/10,101,C12N15/113@Z,A61P3/06,A61P3/00,A61P29/00,A61P1/16,A61K45/00,A61K31/713,A61K31/712,A61P9/00,A61P43/00,111,A61P43/00,105
Stage: Grant (IP right granted following substantive examination.)
Filing Date: March 7, 2024
Publication Date: June 18, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
